Interventional thrombectomy for major stroke-a step in the right direction

New England Journal of Medicine

Volumn 372, Issue 1, 2015, Pages 76-77

  Hacke, Werner ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL STUDY; EDITORIAL; EMBOLECTOMY SYSTEM; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; INTERVENTION STUDY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE CEREBRAL ARTERY; MULTICENTER STUDY (TOPIC); OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PERCUTANEOUS THROMBECTOMY; POLITICAL PARTICIPATION; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; RECANALIZATION; SURGICAL MORTALITY; THROMBECTOMY DEVICE; FEMALE; MALE; MECHANICAL THROMBECTOMY; STROKE;

BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MECHANICAL THROMBOLYSIS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84920502153     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1413346     Document Type: Editorial

References (11)

1. Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous throm-bolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 August 5 (Epub ahead of print).
2. Riedel CH, Zimmermann P, Jensen-Kondering U, Stingele R, Deuschl G, Jansen O. The importance of size: successful recan-alization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke 2011;42:1775-7.
3. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893-903.
4. Erratum, N Engl J Med 2013;368:1265.
5. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368:904-13.
6. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368:914-23.
7. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-9.
8. Khatri P, Yeatts SD, Mazighi M, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol 2014;13:567-74.
9. Mazighi M, Chaudhry SA, Ribo M, et al. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation 2013;127:1980-5.
10. Hacke W, Furlan AJ. (Here comes that) razors edge-endo-vascular stroke therapy: the end, or only the beginning? Int J Stroke 2013;8:331-3.
11. Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11-20.